The results (Figure 6A) indicated that lower TEK expression was significantly associated with advanced tumor stage (T3-T4), lymph node metastasis, higher histologic grade (G3-G4), distant metastasis, advanced clinical stage (Stage III-IV), and sarcomatoid component. Here, TEK is linked to neoplasm.